Alpha-Lipoic Acid for Insulin sensitivity / glucose and Alpha-Lipoic Acid
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
Alpha-Lipoic Acid for Insulin sensitivity / glucose
Evidence grade B — Modest
Grade B1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
Alpha-Lipoic Acid
An antioxidant with genuine evidence for diabetic neuropathy symptoms and modest insulin-sensitivity effects.
Grade B2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Alpha-Lipoic Acid for Insulin sensitivity / glucose | Alpha-Lipoic Acid |
|---|---|---|
| Insulin sensitivity / glucose | Evidence grade BSmall effectmixedModest | Evidence grade BSmall effectmixedModest |
Graded only in Alpha-Lipoic Acid for Insulin sensitivity / glucose
None — every outcome it grades is graded in both.
Graded only in Alpha-Lipoic Acid
- Diabetic neuropathy symptoms Moderate effectEvidence grade B
Conditions
Only in Alpha-Lipoic Acid for Insulin sensitivity / glucose
None.
Only in Alpha-Lipoic Acid
- Diabetic neuropathy ImprovesEvidence grade B
What each entry says about the other
- Alpha-Lipoic Acid for Insulin sensitivity / glucose’s entry · Goes with: Read the full Alpha-Lipoic Acid monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.